These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 27497402

  • 1. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [Abstract] [Full Text] [Related]

  • 2. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ, Glasson C, O'Flaherty SJ.
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [Abstract] [Full Text] [Related]

  • 3. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N, Penn C.
    Int J Lang Commun Disord; 2011 Nov; 46(5):550-63. PubMed ID: 21899672
    [Abstract] [Full Text] [Related]

  • 4. The impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study.
    Sales HF, Cerqueira C, Vaz D, Medeiros-Rios D, Armani-Franceschi G, Lucena PH, Sternberg C, Nóbrega AC, Luz C, Fonseca D, Carvalho AL, Monteiro L, Siqueira IC, Bandeira ID, Lucena R.
    Neurol Res; 2021 Jan; 43(1):54-60. PubMed ID: 32915712
    [Abstract] [Full Text] [Related]

  • 5. US-guided botulinum toxin injection for excessive drooling in children.
    Çiftçi T, Akıncı D, Yurttutan N, Akhan O.
    Diagn Interv Radiol; 2013 Jan; 19(1):56-60. PubMed ID: 22798155
    [Abstract] [Full Text] [Related]

  • 6. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ, Dahl JP, Rose AS.
    Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1387-92. PubMed ID: 24974144
    [Abstract] [Full Text] [Related]

  • 7. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S.
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
    Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hulst K, Gabreëls FJ.
    Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B, Aslami B, Backes H.
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and safety of botulinum toxin in comparison with surgery for drooling in paediatric patients with neurological disorders: a systematic review.
    Silva JPS, Faria LV, Almeida RC, Medeiros YL, Guimarães LDA.
    Br J Oral Maxillofac Surg; 2022 Jun; 60(5):e691-e701. PubMed ID: 35227530
    [Abstract] [Full Text] [Related]

  • 11. Effects of salivary gland botulinum Toxin-A on drooling and respiratory morbidity in children with neurological dysfunction.
    Gubbay A, Marie Blackmore A.
    Int J Pediatr Otorhinolaryngol; 2019 Sep; 124():124-128. PubMed ID: 31185343
    [Abstract] [Full Text] [Related]

  • 12. The Experience of Treating Drooling with Repeated Botulinum Toxin Injections.
    Sillanpää S, Sipilä M, Numminen J, Rautiainen M.
    ORL J Otorhinolaryngol Relat Spec; 2015 Sep; 77(6):333-8. PubMed ID: 26418063
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S, Scheuer E, Buchman AS, Jacobson I, Ben-Zeev B.
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin A for children with salivary control problems.
    Montgomery J, McCusker S, Hendry J, Lumley E, Kubba H.
    Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):1970-3. PubMed ID: 25242701
    [Abstract] [Full Text] [Related]

  • 15. Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review.
    Calim OF, Hassouna HNH, Yildirim YS, Dogan R, Ozturan O.
    Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):104-112. PubMed ID: 30371109
    [Abstract] [Full Text] [Related]

  • 16. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
    Savarese R, Diamond M, Elovic E, Millis SR.
    Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
    [Abstract] [Full Text] [Related]

  • 17. Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.
    Restivo DA, Panebianco M, Casabona A, Lanza S, Marchese-Ragona R, Patti F, Masiero S, Biondi A, Quartarone A.
    Toxins (Basel); 2018 Jan 27; 10(2):. PubMed ID: 29382036
    [Abstract] [Full Text] [Related]

  • 18. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.
    Reid SM, Walstab JE, Chong D, Westbury C, Reddihough DS.
    J Craniofac Surg; 2013 Jan 27; 24(1):28-33. PubMed ID: 23348253
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS.
    Dev Med Child Neurol; 2008 Feb 27; 50(2):123-8. PubMed ID: 18201301
    [Abstract] [Full Text] [Related]

  • 20. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep 27; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.